top of page

Dr Claire Meek

Diabetes in Pregnancy Researcher

Consultant Metabolic Physician

  • Liknedin
  • Twitter

I lead a research group in the field of diabetes in pregnancy at the Institute of Metabolic Science, University of Cambridge. My research focusses on diabetes, nutrition and obesity in pregnancy.


I also work as a diabetes consultant in the diabetes in pregnancy service at Addenbrooke’s and the Rosie hospitals. I see pregnant women with type 1 diabetes, type 2 diabetes, gestational diabetes and previous bariatric surgery. 


Research Interests

Healthy mums, healthy babies, healthy families

I am passionate about improving care for women and babies affected by diabetes in pregnancy, including type 1 diabetes, type 2 diabetes and gestational diabetes. 

Mothers with type 1 or type 2 diabetes have many challenges in pregnancy. Despite the huge amount of commitment and diligence from pregnant mothers, unfortunately pregnancy outcomes are still suboptimal. Many babies suffer complications including excessive growth (large-for-gestational age), low blood glucose levels at birth (neonatal hypoglycaemia), or need neonatal intensive care unit (NICU) admission. My research has focussed on the use of continuous glucose monitoring (CGM) in pregnancy (the CONCEPTT study) and opportunities to predict and prevent complications. 


Gestational diabetes is a form of diabetes which develops during pregnancy and which normally disappears after delivery of the baby. However, it has short-term and long-term implications upon the health of both mum and baby. My main research interest focuses upon improving the health of women with gestational diabetes during pregnancy and in later life, and the health of their children.



Meek CL, Tundidor D, Feig DS, Yamamoto JM, Scott EM, Ma DD, Halperin JA, Murphy HR, Corcoy R; CONCEPTT Collaborative Group. Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes. Diabetes Care. 2021 Mar;44(3):681-689.

Meek CL, Lindsay RS, Scott EM, et al. Approaches to screening for hyperglycaemia in pregnant women during and after the COVID-19 pandemic. Diabet Med. 2020; 38(1):e14380.

Napso T, Zhao X, Ibañez Lligoña M, Sandovici I, Kay RG, Gribble F, Reimann F, Meek CL, Hamilton RS, Sferruzzi-Perri AN. Placental secretome map identifies potential diagnostic and treatment targets for pregnancy complications. Accepted Nature Commun Biol. 2021;4(1):701.

bottom of page